Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
98.80
-2.70 (-2.66%)
Apr 17, 2026, 3:00 PM CST
-2.95% (1Y)
| Market Cap | 26.15B +6.1% |
| Revenue (ttm) | 810.48M +52.1% |
| Net Income | -162.95M |
| EPS | -0.62 |
| Shares Out | 264.71M |
| PE Ratio | n/a |
| Forward PE | 103.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,650,400 |
| Average Volume | 3,766,915 |
| Open | 100.33 |
| Previous Close | 101.50 |
| Day's Range | 97.52 - 101.61 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | -0.00 |
| RSI | 56.06 |
| Earnings Date | Mar 28, 2026 |